Those of you who have followed my blogs for a while know that I’ve written about pelvic prolapse a few times — once about daVinci surgery and another time regarding a clinical study that was set up to see if synthetic mesh inserted through a vaginal incision is beneficial in the repair of pelvic organ prolapse. Pelvic organ prolapse is a relatively common condition caused by the weakening of pelvic muscles and ligaments that support organs such as the bladder and uterus. When this weakening occurs, these organs can slip out of place, often pushing into or through the vagina. Pelvic organ prolapse can be uncomfortable and it can interfere with bowel movements, urination and sexual activity.
Last month another clinical study related to pelvic organ prolapse was described in the American Journal of Obstetrics & Gynecology. This study involved 108 women and compared two pelvic organ prolapse treatment approaches: laparoscopic sacrocolpopexy and total vaginal mesh.
Laparoscopic sacrocolpopexy is a procedure that uses soft synthetic mesh to support pelvic organs that have slipped out of their normal positions. The mesh is initially held in place by friction from strap-like arms of mesh material woven through the pelvis. Body tissues then grow through the mesh, creating the final support. This minimally invasive surgery takes only one to two hours. With the da Vinci Sacrocolpopexy procedure that I offer, the surgery is performed using general anesthesia.
While laparoscopic sacrocolpopexy is performed by laparoscopic access, total vaginal mesh is performed by vaginal access. Another difference is that laparoscopic sacrocolpopexy suspends the mesh from the sacrum — a large, triangular bone at the base of the spine — whereas in a total vaginal mesh procedure the mesh is suspended from pelvic ligaments.
Both procedures have been approved for several years; however, until this study was conducted in Australia, there had never been a controlled trial of this scope.
According to the article in the American Journal of Obstetrics & Gynecology, the study found that despite longer average operating time for laparoscopic sacrocolpopexy (97 minutes vs. 50 minutes for total vaginal mesh), the laparoscopic sacrocolpopexy held several significant advantages over total vaginal mesh: The laparoscopic sacrocolpopexy patients generally experienced fewer days as an inpatient, less blood loss, a shorter catheterization period and a quicker return to regular activities. More importantly, two years after surgery the laparoscopic sacrocolpopexy procedures had a success rate of 77% compared to 43% for the total vaginal mesh procedures. Finally, the reoperation rate (to treat symptoms such as further prolapse, incontinence, and mesh contraction or erosion) was 5% for laparoscopic sacrocolpopexy compared to 22% for total vaginal mesh.
I found these results particularly interesting as well as reassuring, since laparoscopic sacrocolpopexy is the primary pelvic organ prolapse treatment I offer in my practice.
More information on laparoscopic sacrocolpopexy and the da Vinci Sacrocolpopexy procedure can be found here. If you have any questions about these procedures or the symptoms they can be used to treat, please give my office a call.
Dr. John Garofalo, M.D., is gynecologist located in Fairfield County, Connecticut. For more information on Dr. Garofalo and his medical practice, go to www.garofaloobgyn.com. Dr. Garofalo can be reached for a personal consultation at 203.803.1098.